Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism

BACKGROUND: Philadelphia positive leukemias are characterized by the presence of Bcr-Abl fusion protein which exhibits an abnormal kinase activity. Selective Abl kinase inhibitors have been successfully established for the treatment of Ph (+) leukemias. Despite high rates of clinical response, Ph (+...

Descripción completa

Detalles Bibliográficos
Autores principales: Khateb, Mamduh, Ruimi, Nili, Khamisie, Hazem, Najajreh, Yousef, Mian, Afsar, Metodieva, Anna, Ruthardt, Martin, Mahajna, Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561207/
https://www.ncbi.nlm.nih.gov/pubmed/23186157
http://dx.doi.org/10.1186/1471-2407-12-563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561207/
https://www.ncbi.nlm.nih.gov/pubmed/23186157
http://dx.doi.org/10.1186/1471-2407-12-563

Ejemplares similares